Cause‐Specific Mortality in Male US Veterans With Rheumatoid Arthritis
- 21 December 2015
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 68 (1) , 36-45
Abstract
Objective. There has been limited investigation into cause‐specific mortality and the associated risk factors in men with rheumatoid arthritis (RA). We investigated all‐cause and cause‐specific mortality in men with RA, examining determinants of survival. Methods. Men from a longitudinal RA registry were followed from enrollment until death or through 2013. Vital status and cause of death were determined using the National Death Index. Crude mortality rates and standardized mortality ratios (SMRs) were calculated for all‐cause, cardiovascular disease (CVD), cancer, and respiratory mortality. Associations with all‐cause and cause‐specific mortality were examined using multivariable Cox proportional hazards and competing‐risks regression. Results. There were 1,652 men with RA and 332 deaths. CVD (31.6%; SMR 1.77, 95% CI 1.46‐2.14), cancer (22.9%; SMR 1.50; 95% CI 1.20‐1.89), and respiratory disease (15.1%; SMR 2.90; 95% CI 2.20‐3.83) were the leading causes of death. Factors associated with all‐cause mortality included older age, Caucasian race, smoking, low body weight, comorbidity, disease activity, and prednisone use. Rheumatoid factor concentration was associated with CVD mortality, while nodules were associated with CVD and respiratory mortality. There were no associations of methotrexate or biologic use with all‐cause or cause‐specific mortality. Conclusions. Men in this RA cohort experienced increased all‐cause and cause‐specific mortality, with a 3‐fold risk of respiratory‐related deaths compared to age‐matched men in the general population. Further studies are needed to examine whether interventions targeting potentially “modifiable” correlates of mortality might lead to improved long‐term survival in men with RA.Keywords
Funding Information
- Rheumatology Research Foundation Resident Research Preceptorship
- Rheumatology Research Foundation Investigator Award
- Rheumatology Research Foundation Scientific Development Award
- Veterans Affairs Merit Award
This publication has 34 references indexed in Scilit:
- Competing risks in epidemiology: possibilities and pitfallsInternational Journal of Epidemiology, 2012
- Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione s-transferasein a cross-sectional studyArthritis Research & Therapy, 2010
- No evidence of association between anti–tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2010
- Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registryRheumatology, 2010
- Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritisArthritis Research & Therapy, 2008
- Mortality Rate in Veterans with Multiple Chronic ConditionsJournal of General Internal Medicine, 2007
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988